Your feedback is vital to us as we continue to increase the quality of our services.
You are here:
Date: 13 June 2021
Hypertrophic cardiomyopathy (HCM) is an inherited condition which is characterised by thickening of the heart muscle without another explanation. It affects one in 500 people. Whilst the majority of those affected will live long and healthy lives, symptoms (breathlessness, palpitations, chest pain and blackouts) and potentially serious complications can occur. The Queen Elizabeth Hospital Birmingham has a longstanding service dedicated to the care of individuals with HCM. Our main objectives are to:
- Ensure an accurate diagnosis
- Assess and manage the risk of worrisome heart rhythm abnormalities in the future
- Provide targeted treatment when obstruction of blood flow leaving the heart causes symptoms
- Manage symptoms when the heart muscle becomes weakened
- Perform genetic testing and screening for the condition
- Make information available through access to electronic patient records portal and Cardiomyopathy UK
- Promote involvement in research
The service is run by Dr William Bradlow, with support from colleagues within the cardiology, cardiothoracic, genetics and neurology departments.
How to contact the service
Gina Campbell – Medical Secretary
Tel: 0121 371 5732
University Hospitals Birmingham NHS Foundation Trust is not responsible for the contents or the reliability of external websites and does not necessarily endorse the views expressed within them. Listing should not be taken as endorsement of any kind. We cannot guarantee that links to other websites will work all of the time, and we have no control over the availability of external web pages.
Information about travelling to, staying at and getting around the hospital.
Jobs at UHB
A great place to work. Learn why.